Bharat Biotech’s Covaxin Recommended For Phase II / III Trials On 2-18 Year-Olds
New Delhi: The Subject Expert Committee (SEC) on Wednesday gave its nod to Bharat Biotech for the phase 2 and 3 human clinical trials of its Covid-19 vaccine Covaxin on 2 to 18-year-olds, according to reports.
The trial will take place…